Orexigen Therapeutics, Inc. — key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2016)

$33.7M

Net Income/Loss (FY2016)

-$24.5M

Total Assets (FY2016)

$304.6M

Total Equity (FY2016)

$57.0M

Cash Flows from Operating Activities (FY2016)

-$109.7M

Source: Orexigen Therapeutics, Inc. 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.